martes, 10 de marzo de 2015

National Guideline Clearinghouse | Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

full-text ►

National Guideline Clearinghouse | Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.



U.S. Preventive Services Task Force

National Guideline Clearinghouse (NGC)

Guideline Title
Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.
Bibliographic Source(s)
U.S. Preventive Services Task Force. Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014 Dec 2;161(11):819-26. [18 references]PubMed External Web Site Policy
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore (MD): Williams & Wilkins; 1996. Chapter 70, Aspirin prophylaxis in pregnancy. p. 853-59. [31 references].
This guideline meets NGC's 2013 (revised) inclusion criteria.
.....



Low-dose aspirin use for the prevention of morbidity and mortality ... - PubMed - NCBI



 2014 Dec 2;161(11):819-26. doi: 10.7326/M14-1884.

Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Abstract

DESCRIPTION:

Update of the 1996 U.S. Preventive Services Task Force (USPSTF) recommendation on aspirin prophylaxis in pregnancy.

METHODS:

The USPSTF reviewed the evidence on the effectiveness of low-dose aspirin in preventing preeclampsia in women at increased risk and in decreasing adverse maternal and perinatal health outcomes, and assessed the maternal and fetal harms of low-dose aspirin during pregnancy.

POPULATION:

This recommendation applies to asymptomatic pregnant women who are at increased risk for preeclampsia and who have no prior adverse effects with or contraindications to low-dose aspirin.

RECOMMENDATION:

The USPSTF recommends the use of low-dose aspirin (81 mg/d) as preventive medication after 12 weeks of gestation in women who are at high risk for preeclampsia. (B recommendation).

PMID:
 
25200125
 
[PubMed - in process]

No hay comentarios:

Publicar un comentario